Singleton J Matthew (CIK 0001243514)

Latest company ownership

Shares held
25,500
Last filed at
Oct 25, 2024
Confidence Score
49.8
2025Q4
Confidence Score History
2018Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 25, 2024 Oct 25, 2024 Viking Therapeutics, Inc. Director Sell 5.0 -16,000 -62.75% ✓ $1.3M
Sep 20, 2024 Sep 20, 2024 Viking Therapeutics, Inc. Director Sell 7.5 -10,300 -52.02% ✓ $715.9K
Aug 21, 2024 Aug 22, 2024 Viking Therapeutics, Inc. Director Sell 7.5 -5,700 -37.50% ✓ $397.4K
Aug 19, 2024 Aug 19, 2024 Viking Therapeutics, Inc. Director Sell 7.5 -16,000 -62.75% ✓ $995.5K
Aug 14, 2024 Aug 14, 2024 Viking Therapeutics, Inc. Director Sell 5.0 -20,786 -68.63% ✓ $1.2M
May 31, 2018 May 31, 2018 Viking Therapeutics, Inc. Director Buy 95.0 +9,500 100.00% ✗ $93.3K